Endocyte To Raise $30 Million

Endocyte Inc., a West Lafayette, Ind.-based developer of receptor-targeted smart drugs for the treatment of cancer and autoimmune diseases, is looking to raise $30 million in Series D funding, according to VentureWire. The company already has raised over $45 million from firms like Blue Chip Venture Co., Burrill & Co., CID Equity Partners, Sanderling Ventures, Triathlon Medical Ventures and Twilight Venture Partners. www.endocyte.com< ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />